The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference have highlighted limitations in the current treatment of patients with Psoriatic Arthritis (PsA).
Jun 15, 2017
1
0
A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer ...
May 15, 2017
0
55
Declines in prostate specific antigen (PSA) testing that came after changes in government screening guidelines have abated in recent years, according to a new study. Writing in JAMA Internal Medicine, American Cancer Society ...
Apr 24, 2017
0
0
A new study indicates that higher prostate cancer death rates among black men in the US may be due to a higher risk of developing preclinical prostate cancer as well as a higher risk of that cancer progressing more quickly ...
Apr 24, 2017
0
1
In the past, all forms of metastatic prostate cancer have been considered incurable. In recent years, the FDA has approved six drugs for men with metastatic disease, all of which can increase survival. In a study published ...
Apr 18, 2017
0
6
Men ages 55 to 69 should talk with their health care provider about prostate-specific antigen (PSA)-based screening for prostate cancer. That's according to new recommendations from the U.S. Preventive Services Task Force.
Apr 17, 2017
0
4
(HealthDay)—Fewer than one in three men screened with the prostate-specific antigen (PSA) test for prostate cancer talked about the risks and benefits of the test with their doctor, according to a study published online ...
Apr 12, 2017
0
0
Should middle-aged men get routine blood tests for prostate cancer? An influential health panel that once said no now says maybe. It says certain men may benefit as long as they understand the potential harms.
Apr 11, 2017
0
1
An influential U.S. government advisory panel is dropping its opposition to routine prostate cancer screening in favor of letting men decide for themselves after talking with their doctor.
Apr 11, 2017
0
0
Patients with metastatic prostate cancer whose PSA levels remain high despite initial hormone treatments have historically had poor prognosis, with survival typically in the 1-2 year range. Results of a 40-person clinical ...
Apr 5, 2017
0
1
